Interesting history, from 8 years ago, and I think he has 'done his time'. Thanks for the link. He has done a remarkable job getting us to where we are today, with the Boards he has put together, the science developed and in-development, and the JVs we are now engaged in. Whether it is being optimally executed well at this point remains to be seen. I do know that Codexis, the former partner, is now running rings around DYAI. Emelfarb is a fighter, and a survivor, but it remains to be seen whether he can make this company a winner. It appears that we are well-positioned for the next 12-18 months to see products come to the marketplace. The volume/trend over the past few days is very encouraging, and portends something significantly positive about to come to light. I am hanging in there with 10,000 shares, avg, $1.30
I believe this was a major customer. If one major starts switching supply source, and a lot of your eggs are in that one basket, IG is in a world of hurt, for an extended period of time until they broaden their customer base and make up for that one loss. This goes lower. Mid 3's is a reasonable price to buy. I told the SA author it should be priced where it was ($9-11) in 3 years from now…circumstances now seem to support that contention.
What is wrong w/Emelfarb, and why all these Chinese references? Only problem I have with DYAI is that the opportunity is overwhelming them, and can't be properly handled by a tiny shop like this one. They need to merge/be acquired for a rich buyout price. I don't know what he is waiting for.
Add to these, the price has now dropped 75%, and management nepotism has helped to destroy the company. The flagship site doesn't pay rent, and will soon be shut down. Even #$%$ Fuld skipped out. Have they ever indicated how each of their plants are doing? Have they indicated if they are gaining traction in any segment? They make a claim of account gains, yet their $volume isn't moving….wouldn't that mean that they are also losing accounts at the same rate? Assume everything you have heard is bogus. You are betting on a new manager telling you the truth. Until that happens, and he shows some business acumen (don't know how an IT guy is the one to do it) anyone in this really has an investing death wish. Next 6 months, you'll be under $.05….if they are still in business. IMHO. GLTA..It is a noble idea, nevertheless.
so, mgt is 1)incompetent 2)shady, or 3)both?
why are you in it, is science proven to be the real deal, and what is your reason to own this?
Care to elaborate on the AMBS history. I am a shareholder there.
Re: this deal, too sickening to imagine even a PR with this company. Did you see their filing from January 2015. Would be a disgrace coming from a poor functioning High School student. What is up with Generex Management. I got directed here through Moscato/Pfizer connection. I can't believe these people are serious at this point.
Finally, some very soft-pedaling around their dire financial straits. They are desperate for CAPITAL..CAPITAL..CAPITAL. Big financing needed. At what price and terms? $.20? $.15, $.10? Why would anyone put up capital unless they got incredibly great terms for this ultra-high risk situation? Share price to reflect financing price. Either that or over the next 12 months they'll have to go through a bankruptcy and hopefully come out on the other side. Rubber is hitting the road.Lots of dust will fly here. Best to watch from the sidelines. IMHO.
from 5.20 yesterday, this has breezed down to 4.40. another easy skate to 3.50, then watch out below. the bad news will only become evident to the retail trade at the next cc. too late then. high, high risk. someone else maybe will be rewarded but it probably won't be long term holders from here.
How about a double digit sales decline, increasing losses, big investment in "drinks" marketing and promotion, increased commitment to 'vertical' business structure….you got me convinced, they are going to go bust, or Brad is out by the summer/fall. OTOH, lots of dilution may postpone the inevitable if this market stays airborne. If the market is weak, Brad is gone, and company sold for nickels on the dollar.
agree with you. but unless the increased risk burden is somehow mitigated, I see a potential calamity in the making. Replacing Brad with a Pepsico/serious CEO would bump a double plus overnight. Probably won't happen until a horrible quarter is reported. Let's see how Q1 results look. You might see $3 once again.
Yes, huge investment required for a drinks business. Until an analyst puts out a report indicating their financial model for this inherently "different" operating business, this is a MUCH BIGGER risk than it was before. Drinks have been the downfall of almost every small company. I can't imagine how they can do this, have their basic line-up sku's change, take on the ingredients company and now a push into drinks. This operation will be hemorrhaging cash. Someone will rescue them at a very good/low price in 2017-2018. All could be different if the bottlers take on the risk, and if MSLP takes a hefty royalty…that would be smart…but what is the likelihood that Brad would do that? Wait and see.
From the CC, it seems like this volume damage may continue through the current quarter, and perhaps could accelerate. Who knows if the biggest accounts are still in the process of 'rationalizing' their mix. If the biggest accounts are rationalizing the line-up (cutting items from their mix) this will mean volume loss, increased marketing expenses (closeouts, etc.). As MSLP brings in more 'customized' items, this also infers increased marketing expenses, and again, drawing down and pulling standard units from their customers' stock. In total, it will be a short-term mess, with a capital M. Much, much larger companies would have difficulty dealing with this type of complexity. I think there will be an additional shock to the system when Q1 numbers are put out. After that, it may be quite interesting. I am a bit concerned about expansion offices in Brazil, Ireland, etc. while they are loosing $15M per quarter here in the USA. They are uncontrolled in their spending. Can't do everything, and risk the whole boat. Where are the adults? Brad is Emperor??
Company is now staffed with very bright folks who have been attracted by a big technological concept for this industry sector. I have a full position. Waiting for progress to start to become evident over the next 1-3 months. Big opportunity ahead.
Listened to CC. Have no idea what the future holds, although I had hoped he would have provided a bit more understanding of the value of the Chinese partner (how that would work), and the value of ACKinetics. I am a bit surprised that management believes that branding lighting products with an electric flooring brand (HOOVER) creates any benefit whatsoever. What are they thinking. I don't get it. And they are willing to stake a huge amount of cost, upheaval to their inventory/logistics, customer relations, retail positioning, sales execution, all for a change to the HOOVER name? Hunh? This was a risky investment. It got much more risky. I would only take an investment if ACKinetics R&D got incorporated in a big way in truly ground-breaking products. Until that happens, this is worse than Vegas odds. Hoping that ACK can be the hero here.